Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Inventory (2023 - 2024)

Roivant Sciences' Inventory history spans 2 years, with the latest figure at $34.0 million for Q2 2024.

  • For Q2 2024, Inventory rose 704.66% year-over-year to $34.0 million; the TTM value through Jun 2024 reached $34.0 million, up 704.66%, while the annual FY2024 figure was $35.3 million, 1176.75% up from the prior year.
  • Inventory reached $34.0 million in Q2 2024 per ROIV's latest filing, down from $35.3 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $35.3 million in Q1 2024 to a low of $2.8 million in Q1 2023.